Entropy Technologies, LP Bristol Myers Squibb CO Transaction History

Entropy Technologies, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$39.66 - $51.75 $1.03 Million - $1.35 Million	-26,086 Reduced 19.17%	110,022 $5.69 Billion
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $5.48 Million - $7.21 Million	136,108 New	136,108 $5.65 Billion
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $567,312 - $676,960	11,702 New	11,702 $600 Million

2,578

1.46B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

Stay updated on Entropy Technologies, LP with notifications on news.